A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome
Jurjen M. Ruben, Charlotte M. Mousset, Dorien van de Berg, Kim Hofman, Milon de Jong, Patricia Brouwer, Sanne Graeve, Victoria Iglesias-Guimarais, Pauline M. van Helden, Anton E.P. Adang, Rob C. Roovers, Hans J. van der Vliet Clinical Immunology
· Elsevier
· DOI: 10.1016/j.clim.2026.110786
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Jurjen M. Ruben, Charlotte M. Mousset, Dorien van de Berg, Kim Hofman, Milon de Jong, Patricia Brouwer et al. A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome. // Clinical Immunology. – DOI: 10.1016/j.clim.2026.110786. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626001245?dgcid=rss_sd_all
Jurjen M. Ruben, Charlotte M. Mousset, Dorien van de Berg, Kim Hofman, Milon de Jong, Patricia Brouwer, Sanne Graeve, Victoria Iglesias-Guimarais, Pauline M. van Helden, Anton E.P. Adang, Rob C. Roovers, & Hans J. van der Vliet A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome. Clinical Immunology. https://doi.org/10.1016/j.clim.2026.110786
Jurjen M. Ruben, et al. “A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome.” Clinical Immunology. doi:10.1016/j.clim.2026.110786.
@article{Ruben,
title = {A novel CD123xVδ2 bispecific T cell engager induces potent and tumor selective Vγ9Vδ2-T cell activity against CD123 expressing acute myeloid leukemia and myelodysplastic syndrome},
author = {Ruben, Jurjen M. and Mousset, Charlotte M. and Berg, Dorien van de and Hofman, Kim and Jong, Milon de and Brouwer, Patricia and Graeve, Sanne and Iglesias-Guimarais, Victoria and Helden, Pauline M. van and Adang, Anton E.P. and Roovers, Rob C. and Vliet, Hans J. van der},
journal = {Clinical Immunology},
doi = {10.1016/j.clim.2026.110786},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626001245?dgcid=rss_sd_all}
}
Mesenchymal stem cells (MSCs) have emerged as promising therapeutic agents in regenerative medicine, with their therapeutic effects increasingly attributed to intercellular communication and microenvironmental regulation rather than...
Background Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. Methods We analyzed GEO...
Background Lung cancer is one of the leading causes of cancer-related mortality worldwide. Understanding the molecular mechanisms underlying lung cancer progression is critical for identifying novel therapeutic targets. This study...